Iterum Therapeutics   Report issue

For profit Phase 3 Phase 4
Founded: Dublin Ireland (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2017
NCT03366207
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Iterum Therapeutics | Iterum Therapeutics, International Limited | Iterum Therapeutics, US Limited